AlphaYouKM
Insider selling
Kevin Mcculloch sold $250K of Xeris Biopharma Holdings, Inc. (XERS) stock
Kevin Mcculloch sold 25,000 shares of XERS stock worth $250K, per an SEC Form 4 filed Sep 29, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 28, 2026, 1 day before it was made public.
XERS has moved +1.5% since the trade date, from $9.83 to $9.98 (Sep 29, 2026 close).
- Traded
- Sep 28, 2026
- Disclosed
- Sep 29, 2026
- Filing delay
- 1 day
- Price since
- +1.5%
- Source
- SEC Form 4
More XERS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.